Reintroduction of foot-and-mouth disease in Argentina: Characterisation of the isolates and development of tools for the control and eradication of the disease

Vaccine

Volumn 22, Issue 31-32, 2004, Pages 4149-4162

  Mattion, Nora ^a   König, Guido ^b   Seki, Cristina ^a   Smitsaart, Eliana ^c   Maradei, Eduardo ^d   Robiolo, Blanca ^a   Duffy, Sergio ^b   León, Emilio ^b   Piccone, María ^b   Sadir, Ana ^b   Bottini, Rodolfo ^d   Cosentino, Bernardo ^d   Falczuk, Abraham ^d   Maresca, Ricardo ^d   Periolo, Osvaldo ^d   Bellinzoni, Rodolfo ^c   Espinoza, Ana ^c   Torre, José La ^a   Palma, Eduardo L ^b  

^a Centro de Virologia Animal   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^c Biogenesis Bago   (Argentina)

^d Servicio Nacional de Sanidad y Calidad Agroalimentaria Argentina   (Argentina)

Author keywords

FMD vaccine bank; FMD vaccine updating; FMDV genomic sequencing; Foot and mouth disease virus; Monoclonal antibodies profiling; PPG challenge

Indexed keywords

ANTIBODY; FOOT AND MOUTH DISEASE VACCINE; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL TISSUE; ANTIGENICITY; ARGENTINA; ARTICLE; CATTLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; EPIDEMIC; ERADICATION THERAPY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE SEQUENCE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAMPAS; PRIORITY JOURNAL; SEROTYPE; TIME SERIES ANALYSIS; VACCINATION; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; ARGENTINA; CATTLE; CATTLE DISEASES; CHEMISTRY, PHARMACEUTICAL; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNIZATION; NEUTRALIZATION TESTS; RNA, VIRAL; VIRAL PROTEINS; VIRAL VACCINES;

EID: 4944222602     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.040     Document Type: Article

References (25)

1. J.C. Pizzi Foot and mouth disease in Argentina Eudeba 1998 247 282
2. M.M. Rweyemamu, Pay TWF, and M.J. Parker Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses Dev Biol Stand 35 1977 205 214
3. I.J. Reed, and R.H. Müench A simple method to estimate fifty percent end points Am J Hyg 27 1938 493 497
4. N. Ferris, and A.I. Donaldson The world reference laboratory for Foot-and-mouth disease: a review of 33 years of activity Rev Sci Tech Off Int Epiz 11 1992 657 684
5. E.M. Earley, and J.C. Rener Hybridoma technology I: murine monoclonal antibodies J Tissue Culture Methods 9 3 1985 129 187
6. A.R. Samuel, N.J. Knowles, G.D. Samuel, and J.R. Crowther Evaluation of trapping ELISA for differentiation of foot-and-mouth disease virus strains using monoclonal antibodies Biologicals 19 1991 299 310
7. G. König, C. Blanco, N.J. Knowles, E.L. Palma, E. Maradei, and M.E. Piccone Phylogenetic analysis of foot-and-mouth disease virus isolated in Argentina Virus Genes 23 2 2001 175 181
8. Knowles NJ, Samuel AR. Polymerase chain reaction amplification and cycle sequencing of the 1D (VP1) gene of foot-and-mouth disease viruses. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, 1995;Appendix 8:45-53.
9. J.D. Thompson, T.J. Gibson, F. Plewniak, F. Jeanmougin, and D.G. Higgins The Clustal X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools Nucleic Acids Res 24 1997 4876 4882
10. H.G. Bahneman Binary etylenimine as an inactivant for foot-and-mouth disease and its application for vaccine production Arch. Virol. 47 1 1975 47 56
11. N. Mattion, E. Smitsaart, M. Mazza, N. Harrison, J. Filippi, and B. Robiolo Emergency vaccine for foot-and-mouth disease: early immunity induction in susceptible species Vet Argentina 148 1998 563 572
12. B. Robiolo, P.R. Grigera, O.H. Periolo, C. Seki, T. Bianchi, and E. Maradei Assessment of foot-and-mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina Vaccine 13 1995 1346 1352
13. I. Bergmann, V. Malirat, E. Neitzert, E. Beck, N. Panizzutti, and C. Sánchez Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay Arch Virol 145 3 2000 473 489
14. A. Alonso Fernández, Gómes MPD, M.A. Martins, and M.S. Sondahl Detection of foot-and-mouth disease virus infection associated antigen antibodies: Comparison of the enzyme-linked immunosorbent assay and agar gel immunodiffusion test Prev Vet Med 9 1990 233 240
15. J.P. Araújo, H.J. Montassier, and A.A. Pinto Extensive antigenic and genetic variation among foot-and-mouth disease type A viruses isolated from the 1994 and 1995 foci in Sao Paulo Braz Vet Microbiol 84 2002 15 27
16. G.N. Wedell, D.G. Yansura, D.J. Dowbenko, M.E. Hoatlin, M.J. Grubman, and D.M. Moore Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A PNAS USA 82 1985 2618 2622
17. J.I. Núez, M.J. Martín, M.E. Piccone, E. Carrillo, E.L. Palma, and J. Dopazo Identification of optimal regions for phylogenetic studies on VP1 gene of foot-and-mouth disease: analysis of type A and O Argentinean virus Vet Res 32 2001 31 45
18. Office International des Epizooties (OIE). Report 2000;13(33). p 138.
19. Office International des Epizooties (OIE). Report 2000;13(42). p.189.
20. A.R. Samuel, N.J. Knowles, and K.J. Mackay Genetic analysis of type O viruses responsible for epidemics of foot-and-mouth disease in North Africa Epidemiol Infect 122 1999 529 538
21. Barteling SJ, Swam H. The potent aqueous and double oil emulsion foot-and-mouth disease type O1 vaccines from European vaccine banks probably protect against all other O1 strains. Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of FMD. Kibbuts Ma'ale Hachamisha, Israel, 2-6 September 1996. Appendix 13:90-94.
22. P.V. Barnett, A.R. Samuel, and R.J. Statham The suitability of the "emergency" foot-and-mouth disease antigens held by the international vaccine bank within a global context Vaccine 19 2001 2107 2117
23. C. Tami, O. Taboga, A. Berinstein, J. Núez, E. Palma, and E. Domingo Evidence of coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo J Virol 77 2003 1219 1226
24. E. Smitsaart, M. Zanelli, I. Rivera, N. Fondevila, D. Compaired, and E. Maradei Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines Prev Vet J 33 1998 283 296
25. N. Fondevila, V. O'Donnell, S. Duffy, E. León, E. Smitsaart, and A. Schudel Sero-epidemiological indicators for evaluating foot-and-mouth disease control campaigns Rev Sci Tech Off Int Epiz 16 3 1997 784 792